Despite the emergence of prostate-specific antigen (PSA) screening-powered earlier detection of PCa, the limited specificity of PSA results in its unsatisfying performance in serving as an ideal biomarker3. This evidence concerns the gene KLK3 and posterior cortical atrophy.